Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, Koebnick C
Dosing frequency GLP-1s vary in their dosing frequency, which can significantly impact patient adherence and preference: Twice-daily: Exenatide (Byetta) Once-daily: Liraglutide (Victoza, Saxenda), Semaglutide tablets (Rybelsus) Once-weekly: Semaglutide (Ozempic, Wegovy), Dulaglutide (Trulicity), Exenatide extended-release (Bydureon), Tirzepatide (Mounjaro, Zepbound) The once-weekly formulations generally offer greater convenience and may improve adherence
5mg per dose Primary Benefits Delivers sustained growth hormone-releasing hormone activity with extended half-life for prolonged pituitary stimulation and consistent GH levels
Nuclei were stained with 5 g/mL DAPI
View Trial Registration Wilding JPH, Batterham RL, Calanna S, et al